Uncoupling Protein-2 Is Critical for Nigral Dopamine Cell Survival in a Mouse Model of Parkinson's Disease

Mitochondrial uncoupling proteins dissociate ATP synthesis from oxygen consumption in mitochondria and suppress free-radical production. We show that genetic manipulation of uncoupling protein-2 (UCP2) directly affects substantia nigra dopamine cell function. Overexpression of UCP2 increases mitochondrial uncoupling, whereas deletion of UCP2 reduces uncoupling in the substantia nigra-ventral tegmental area. Overexpression of UCP2 decreased reactive oxygen species (ROS) production, which was measured using dihydroethidium because it is specifically oxidized to fluorescent ethidium by the superoxide anion, whereas mice lacking UCP2 exhibited increased ROS relative to wild-type controls. Unbiased electron microscopic analysis revealed that the elevation of in situ mitochondrial ROS production in UCP2 knock-out mice was inversely correlated with mitochondria number in dopamine neurons. Lack of UCP2 increased the sensitivity of dopamine neurons to 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine (MPTP), whereas UCP2 overexpression decreased MPTP-induced nigral dopamine cell loss. The present results expose the critical importance of UCP2 in normal nigral dopamine cell metabolism and offer a novel therapeutic target, UCP2, for the prevention/treatment of Parkinson's disease.

[1]  J. Weissenbach,et al.  Molecular approach to thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial uncoupling protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Cooper,et al.  Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical Involvement , 1992, Journal of neurochemistry.

[3]  V. Bindokas,et al.  Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  M. Seldin,et al.  BMCP1, a Novel Mitochondrial Carrier with High Expression in the Central Nervous System of Humans and Rodents, and Respiration Uncoupling Activity in Recombinant Yeast* , 1998, The Journal of Biological Chemistry.

[5]  Christophe Fleury,et al.  Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia , 1997, Nature Genetics.

[6]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[7]  T. Horvath,et al.  Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury. , 2002, Biochemical pharmacology.

[8]  Young-Bum Kim,et al.  Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes , 2001, Cell.

[9]  J. Wands,et al.  Uncoupling protein‐2 deficiency promotes oxidant stress and delays liver regeneration in mice , 2004, Hepatology.

[10]  M. Ward,et al.  Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts , 2000, Trends in Neurosciences.

[11]  M. Beal,et al.  Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase , 2004, Neurobiology of Disease.

[12]  T. Horvath,et al.  Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice , 2003, International Journal of Obesity.

[13]  M. Klingenberg,et al.  Uncoupling proteins 2 and 3 are highly active H(+) transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone). , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Dichgans,et al.  Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease , 2000, The Journal of Neuroscience.

[15]  A. Zhong,et al.  UCP4, a novel brain‐specific mitochondrial protein that reduces membrane potential in mammalian cells , 1999, FEBS letters.

[16]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[17]  G. Tomasevic,et al.  Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma , 2003, Nature Medicine.

[18]  S. Sakowski,et al.  Nitrotyrosine as a marker for peroxynitrite‐induced neurotoxicity: the beginning or the end of the end of dopamine neurons? , 2004, Journal of neurochemistry.

[19]  P. Pedersen.  Mitochondrial Events in the Life and Death of Animal Cells: A Brief Overview , 1999, Journal of bioenergetics and biomembranes.

[20]  G. Fiskum,et al.  Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state , 2003, Journal of neurochemistry.

[21]  B. Lowell,et al.  Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. , 2001, Cell.

[22]  L. Andĕra,et al.  Coenzyme Q blocks biochemical but not receptor‐mediated apoptosis by increasing mitochondrial antioxidant protection , 2001, FEBS letters.

[23]  Joel S Perlmutter,et al.  Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. , 2002, Archives of neurology.

[24]  C. Barnstable,et al.  Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. , 2003, Endocrinology.

[25]  Gary Fiskum,et al.  Generation of reactive oxygen species by the mitochondrial electron transport chain , 2002, Journal of neurochemistry.

[26]  M. Klingenberg,et al.  Coenzyme Q is an obligatory cofactor for uncoupling protein function , 2000, Nature.

[27]  O. Steward,et al.  Mitochondrial uncoupling protein‐2 protects the immature brain from excitotoxic neuronal death , 2003, Annals of neurology.

[28]  R. Roth,et al.  Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. , 2003, Endocrinology.

[29]  J. Stuart,et al.  Superoxide activates mitochondrial uncoupling proteins , 2002, Nature.

[30]  M. Beal,et al.  Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice , 1998, Brain Research.

[31]  C. Epstein,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  P. Ježek.  Possible physiological roles of mitochondrial uncoupling proteins--UCPn. , 2002, The international journal of biochemistry & cell biology.

[33]  B. Miroux,et al.  Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production , 2000, Nature Genetics.